Kees Brinkman

12.1k total citations · 3 hit papers
139 papers, 6.0k citations indexed

About

Kees Brinkman is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Kees Brinkman has authored 139 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Infectious Diseases, 50 papers in Epidemiology and 49 papers in Virology. Recurrent topics in Kees Brinkman's work include HIV/AIDS drug development and treatment (51 papers), HIV Research and Treatment (49 papers) and HIV/AIDS Research and Interventions (47 papers). Kees Brinkman is often cited by papers focused on HIV/AIDS drug development and treatment (51 papers), HIV Research and Treatment (49 papers) and HIV/AIDS Research and Interventions (47 papers). Kees Brinkman collaborates with scholars based in Netherlands, United States and United Kingdom. Kees Brinkman's co-authors include Peter Reiss, Jan Smeıtınk, David M. Burger, Johannes A. Romijn, Peter P. Koopmans, Ard van Sighem, Hadewych J. M. ter Hofstede, Frank de Wolf, Suzanne E. Geerlings and Colette Smit and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Kees Brinkman

135 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1999 677 citations Kees Brinkman, Peter Reiss et al. profile →
Adverse effects of reverse transcriptase inhibitors

1998 671 citations Kees Brinkman, David M. Burger et al. AIDS profile →
Future challenges for clinical care of an ageing population infected with HIV: a modelling study

2015 619 citations Kees Brinkman, Suzanne E. Geerlings et al. profile →

Peers

Countries citing papers authored by Kees Brinkman

Since Specialization

Citations

This map shows the geographic impact of Kees Brinkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Brinkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Brinkman more than expected).

Fields of papers citing papers by Kees Brinkman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Brinkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Brinkman. The network helps show where Kees Brinkman may publish in the future.

Co-authorship network of co-authors of Kees Brinkman

This figure shows the co-authorship network connecting the top 25 collaborators of Kees Brinkman. A scholar is included among the top collaborators of Kees Brinkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees Brinkman. Kees Brinkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reducing internalized HIV stigma with Intervention Mapping: the design, implementation, and evaluation of RESET (RESilience and Empowerment Training) 2025 ·AIDS Care ·Sarah E. Stutterheim, (unknown), Roy A. Willems, (unknown), L. Elsenburg, (unknown), (unknown), Chantal den Daas, (unknown), (unknown), Kees Brinkman, Arjan E. R. Bos	0
2	Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk 2025 ·Clinical Infectious Diseases ·(unknown), Ferdinand W.N.M. Wit, Vita W. Jongen, Kees Brinkman, Jan M. Prins, Olivier Richel, Emile F. Schippers, G. van Twillert, Peter Reiss, Marc van der Valk	0
3	Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies 2024 ·Viruses ·W Vos, (unknown), Vasiliki Matzaraki, (unknown), (unknown), Marc J. T. Blaauw, (unknown), Kees Brinkman, (unknown), Niels P. Riksen, Anton F. H. Stalenhoef, Jan van Lunzen, André van der Ven, Willem L. Blok, Janneke E. Stalenhoef	3
4	HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity 2024 ·Frontiers in Immunology ·W Vos, (unknown), (unknown), Marc J. T. Blaauw, (unknown), (unknown), (unknown), (unknown), Vasiliki Matzaraki, Bram van Cranenbroek, Kees Brinkman, Jan van Lunzen, Leo A. B. Joosten, Mihai G. Netea, Willem L. Blok, André van der Ven, Hans J. P. M. Koenen, Janneke E. Stalenhoef	7
5	Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands 2023 ·BMJ Open ·(unknown), R.W.M.M. Jansen, Joris R. de Groot, (unknown), Martin E W Hemels, Renée A. Douma, (unknown), Kees Brinkman, Hazra S. Moeniralam, Martijn D. de Kruif, Tom Dormans, Brent Appelman, Auke C. Reidinga, (unknown), (unknown), (unknown), Martijn Beudel, Suat Şimşek	3
6	What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals 2023 ·BMJ Open ·(unknown), Marije ten Wolde, Martijn Beudel, Rik Olde Engberink, Brent Appelman, (unknown), (unknown), (unknown), Suat Şimşek, (unknown), Joop P. van den Bergh, Caroline E. Wyers, Martijn D. de Kruif, Tom Dormans, Hazra S. Moeniralam, (unknown), Kees Brinkman, Renée Douma	2
7	Testing and healthcare seeking behavior preceding HIV diagnosis among migrant and non-migrant individuals living in the Netherlands: Directions for early-case finding 2022 ·PLoS ONE ·(unknown), (unknown), Jan M. Prins, Kees Brinkman, Eliane M.S. Leyten, Ard van Sighem, (unknown), Udi Davidovich, Fiona Burns, Maria Prins	5
8	Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis 2022 ·The Lancet Regional Health - Europe ·(unknown), Maarten F. Schim van der Loeff, Anders Boyd, Udi Davidovich, Marc van der Valk, Kees Brinkman, Kim Sigaloff, Judith Branger, (unknown), Godelieve J. de Bree, Peter Reiss, Jan van Bergen, Suzanne E. Geerlings	10
9	Role of Self-Stigma in Pathways from HIV-Related Stigma to Quality of Life Among People Living with HIV 2021 ·AIDS Patient Care and STDs ·(unknown), (unknown), Chantal den Daas, Guido E.L. van den Berk, (unknown), (unknown), (unknown), (unknown), Peter Verboon, Kees Brinkman, Arjan E. R. Bos, Sarah E. Stutterheim	42
10	Disparities in access to and use of HIV-related health services in the Netherlands by migrant status and sexual orientation: a cross-sectional study among people recently diagnosed with HIV infection 2019 ·BMC Infectious Diseases ·(unknown), Freke Zuure, Débora Álvarez-del Arco, Jan M. Prins, Kees Brinkman, Eliane M.S. Leyten, Ard van Sighem, Fiona Burns, Maria Prins	24
11	A Survey of Patients’ Perspectives on Outpatient HIV Care in the Netherlands 2017 ·Infectious Diseases and Therapy ·(unknown), Colette Smit, Frank P. Kroon, Pythia T. Nieuwkerk, Peter Reiss, Kees Brinkman, Suzanne E. Geerlings	6
12	Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands 2015 ·AIDS ·(unknown), Colette Smit, Ard van Sighem, Peter Reiss, Pythia T. Nieuwkerk, Frank P. Kroon, Kees Brinkman, Suzanne E. Geerlings	10
13	Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection 2014 ·AIDS ·(unknown), (unknown), Guido E.L. van den Berk, (unknown), (unknown), Lea M. Dijksman, (unknown), Kees Brinkman	4
14	Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy 2010 ·Viral Immunology ·Ingrid M. M. Schellens, Katalin Pogány, Geertje H. A. Westerlaken, José A. M. Borghans, Frank Miedema, Irene G. M. van Valkengoed, Frank P. Kroon, Joep M. A. Lange, Kees Brinkman, Jan M. Prins, Debbie van Baarle	1
15	Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus 2005 ·Virology ·Nico Kloosterboer, P. H. P. Groeneveld, Christine A. Jansen, (unknown), Frits Koning, (unknown), Ashley J. Duits, Frank Miedema, Debbie van Baarle, Ronald P. van Rij, Kees Brinkman, Hanneke Schuitemaker	24
16	Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals 2003 ·AIDS ·David M. Burger, Patricia W. H. Hugen, Peter Reiss, Inge C. Gyssens, M. M. E. Schneider, Frank P. Kroon, Gerrit Schreij, Kees Brinkman, Clemens Richter, Jan M. Prins, Rob E. Aarnoutse, Joep M. A. Lange	119
17	Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes 1990 ·Journal of Autoimmunity ·Rose-Marie Termaat, Kees Brinkman, F. Van Gompel, Lambert P.W.J. van den Heuvel, Jacques H. Veerkamp, Ruud J.T. Smeenk, Jo H. M. Berden	75
18	Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations 1990 ·Clinical & Experimental Immunology ·Rose-Marie Termaat, Kees Brinkman, Johannes C. Nossent, A. J. G. Swaak, Ruud J.T. Smeenk, (unknown)	32
19	Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? 1989 ·PubMed ·Jo H. M. Berden, Rose-Marie Termaat, Kees Brinkman, R J Smeenk, A. J. G. Swaak, P. Faaber, K.J.M. Assmann, (unknown), J.H. Veerkamp	9
20	Reaction patterns of monoclonal antibodies to DNA. 1988 ·The Journal of Immunology ·R J Smeenk, Kees Brinkman, H G van den Brink, (unknown)	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact